These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8650232)

  • 1. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94.
    Nieland TJ; Tan MC; Monne-van Muijen M; Koning F; Kruisbeek AM; van Bleek GM
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6135-9. PubMed ID: 8650232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-step purification of gp96 from human liver tumor tissues suitable for isolation of gp96-bound peptides.
    Meng SD; Song J; Rao Z; Tien P; Gao GF
    J Immunol Methods; 2002 Jun; 264(1-2):29-35. PubMed ID: 12191506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of peptide loading by the tumor rejection antigen/heat shock chaperone gp96 (GRP94).
    Sastry S; Linderoth N
    J Biol Chem; 1999 Apr; 274(17):12023-35. PubMed ID: 10207025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
    Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
    Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96.
    Breloer M; Marti T; Fleischer B; von Bonin A
    Eur J Immunol; 1998 Mar; 28(3):1016-21. PubMed ID: 9541597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunity.
    Nicchitta CV; Carrick DM; Baker-Lepain JC
    Cell Stress Chaperones; 2004; 9(4):325-31. PubMed ID: 15633290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression levels of stress protein gp96 are not limiting for major histocompatibility complex class I-restricted antigen presentation.
    Lammert E; Arnold D; Rammensee HG; Schild H
    Eur J Immunol; 1996 Apr; 26(4):875-9. PubMed ID: 8625982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.
    Ménoret A; Peng P; Srivastava PK
    Biochem Biophys Res Commun; 1999 Sep; 262(3):813-8. PubMed ID: 10471407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cytotoxic T cells in vitro by recombinant gp96 fusion proteins irrespective of the 'fused' antigenic peptide sequence.
    Moré S; Breloer M; Fleischer B; von Bonin A
    Immunol Lett; 1999 Aug; 69(2):275-82. PubMed ID: 10482363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule.
    Van Bleek GM; Nathenson SG
    Nature; 1990 Nov; 348(6298):213-6. PubMed ID: 1700303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer of GRP94(Gp96)-associated peptides onto endosomal MHC class I molecules.
    Berwin B; Rosser MF; Brinker KG; Nicchitta CV
    Traffic; 2002 May; 3(5):358-66. PubMed ID: 11967129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.
    Basu S; Binder RJ; Ramalingam T; Srivastava PK
    Immunity; 2001 Mar; 14(3):303-13. PubMed ID: 11290339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the peptide-binding site in the heat shock chaperone/tumor rejection antigen gp96 (Grp94).
    Linderoth NA; Popowicz A; Sastry S
    J Biol Chem; 2000 Feb; 275(8):5472-7. PubMed ID: 10681525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
    Nair S; Wearsch PA; Mitchell DA; Wassenberg JJ; Gilboa E; Nicchitta CV
    J Immunol; 1999 Jun; 162(11):6426-32. PubMed ID: 10352256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
    Li Z; Srivastava PK
    EMBO J; 1993 Aug; 12(8):3143-51. PubMed ID: 8344253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
    Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
    Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
    Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
    Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein gp96 and cancer immunotherapy.
    Peibin Y; Shude Y; Changzhi H
    Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.